Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00407186 |
Recruitment Status :
Active, not recruiting
First Posted : December 4, 2006
Last Update Posted : October 10, 2017
|
Sponsor:
Dutch Colorectal Cancer Group
Collaborators:
The Netherlands Cancer Institute
Roche Pharma AG
Information provided by (Responsible Party):
Dutch Colorectal Cancer Group
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | December 2018 |
Estimated Study Completion Date : | December 2025 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):